个人中心 - 老虎社区

firstfruits

IP属地：未知

帖子 · 7帖子 · 7
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- firstfruitsfirstfruits
  ·2021-09-09
  generic and biosimilar should be advantaged by this policy
  White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.
  The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according
  White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.
  1,776 1
  5
  分享
  举报
- firstfruitsfirstfruits
  ·2021-06-15
  ouch
  BRIEF-Novavax Filed Prospectus Supplement With SEC Which Contemplates Sale Of Up To $500 Mln Of Shares
  June 15 (Reuters) - Novavax Inc : * NOVAVAX - ON JUNE 15 FILED PROSPECTUS SUPPLEMENT WITH SEC WH
  BRIEF-Novavax Filed Prospectus Supplement With SEC Which Contemplates Sale Of Up To $500 Mln Of Shares
  1,888 评论
  点赞
  分享
  举报
- firstfruitsfirstfruits
  ·2021-06-11
  another softbank company
  非常抱歉，此主贴已删除
  1,298 评论
  3
  分享
  举报
- firstfruitsfirstfruits
  ·2021-06-11
  it is just transistory!
  非常抱歉，此主贴已删除
  1,256 评论
  3
  分享
  举报
- firstfruitsfirstfruits
  ·2021-02-16
  really??
  With Biden going big, Wall Street economists are growing bullish on the US economy
  New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a doubl
  With Biden going big, Wall Street economists are growing bullish on the US economy
  1,360 1
  1
  分享
  举报
- firstfruitsfirstfruits
  ·2021-02-02
  nice!!!
  非常抱歉，此主贴已删除
  1,332 评论
  点赞
  分享
  举报
- firstfruitsfirstfruits
  ·2021-02-02
  nice
  非常抱歉，此主贴已删除
  1,151 评论
  点赞
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3562413816387860","uuid":"3562413816387860","gmtCreate":1599321019611,"gmtModify":1612236745709,"name":"firstfruits","pinyin":"firstfruits","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/10628f9c1ecd1b1ed688fe5c74ad3511","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":6,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.75%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":883928961,"gmtCreate":1631197382853,"gmtModify":1632884003789,"author":{"id":"3562413816387860","authorId":"3562413816387860","name":"firstfruits","avatar":"https://static.tigerbbs.com/10628f9c1ecd1b1ed688fe5c74ad3511","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562413816387860","authorIdStr":"3562413816387860"},"themes":[],"htmlText":"generic and biosimilar should be advantaged by this policy","listText":"generic and biosimilar should be advantaged by this policy","text":"generic and biosimilar should be advantaged by this policy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883928961","repostId":"1176976417","repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"<p>The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from <i>The Wall Street Journal</i>.</p>\n<p>The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the <i>Journal</i> report.</p>\n<p>The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.</p>\n<p>The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech</p>\n<p>exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.</p>\n<p>Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.</p>\n<p><img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"></p>\n<p>Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.</p>\n<p>According to the <i>Journal</i>, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.</p>\n<p>“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”</p>\n<p>Lilly CEO David Ricks also spoke on the call.</p>\n<p>“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.</p>\n<p>In addition to the drug-pricing plan, the <i>New York Times</i> reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","PFE":"辉瑞","LLY":"礼来"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"LLY":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1776,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160057594,"gmtCreate":1623767506118,"gmtModify":1634028609639,"author":{"id":"3562413816387860","authorId":"3562413816387860","name":"firstfruits","avatar":"https://static.tigerbbs.com/10628f9c1ecd1b1ed688fe5c74ad3511","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562413816387860","authorIdStr":"3562413816387860"},"themes":[],"htmlText":"ouch","listText":"ouch","text":"ouch","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160057594","repostId":"2143075110","repostType":2,"repost":{"id":"2143075110","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623761427,"share":"https://www.laohu8.com/m/news/2143075110?lang=&edition=full","pubTime":"2021-06-15 20:50","market":"us","language":"en","title":"BRIEF-Novavax Filed Prospectus Supplement With SEC Which Contemplates Sale Of Up To $500 Mln Of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2143075110","media":"Reuters","summary":"June 15 (Reuters) - Novavax Inc   :   * NOVAVAX - ON JUNE 15 FILED PROSPECTUS SUPPLEMENT WITH SEC WH","content":"<html><body><p>June 15 (Reuters) - Novavax Inc   :</p><p>   * NOVAVAX - ON JUNE 15 FILED PROSPECTUS SUPPLEMENT WITH SEC WHICH CONTEMPLATES SALE OF UP TO $500 MILLION OF SHARES OF CO'S COMMON STOCK</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Novavax Filed Prospectus Supplement With SEC Which Contemplates Sale Of Up To $500 Mln Of Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Novavax Filed Prospectus Supplement With SEC Which Contemplates Sale Of Up To $500 Mln Of Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-15 20:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>June 15 (Reuters) - Novavax Inc   :</p><p>   * NOVAVAX - ON JUNE 15 FILED PROSPECTUS SUPPLEMENT WITH SEC WHICH CONTEMPLATES SALE OF UP TO $500 MILLION OF SHARES OF CO'S COMMON STOCK</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143075110","content_text":"June 15 (Reuters) - Novavax Inc   :   * NOVAVAX - ON JUNE 15 FILED PROSPECTUS SUPPLEMENT WITH SEC WHICH CONTEMPLATES SALE OF UP TO $500 MILLION OF SHARES OF CO'S COMMON STOCKSource text for Eikon: [ Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":1888,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188963708,"gmtCreate":1623419584904,"gmtModify":1634033449505,"author":{"id":"3562413816387860","authorId":"3562413816387860","name":"firstfruits","avatar":"https://static.tigerbbs.com/10628f9c1ecd1b1ed688fe5c74ad3511","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562413816387860","authorIdStr":"3562413816387860"},"themes":[],"htmlText":"another softbank company","listText":"another softbank company","text":"another softbank company","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/188963708","repostId":"1118478259","repostType":4,"isVote":1,"tweetType":1,"viewCount":1298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188914413,"gmtCreate":1623419279332,"gmtModify":1634033459780,"author":{"id":"3562413816387860","authorId":"3562413816387860","name":"firstfruits","avatar":"https://static.tigerbbs.com/10628f9c1ecd1b1ed688fe5c74ad3511","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562413816387860","authorIdStr":"3562413816387860"},"themes":[],"htmlText":"it is just transistory!","listText":"it is just transistory!","text":"it is just transistory!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/188914413","repostId":"1196090491","repostType":4,"isVote":1,"tweetType":1,"viewCount":1256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382471502,"gmtCreate":1613479791306,"gmtModify":1634553500655,"author":{"id":"3562413816387860","authorId":"3562413816387860","name":"firstfruits","avatar":"https://static.tigerbbs.com/10628f9c1ecd1b1ed688fe5c74ad3511","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562413816387860","authorIdStr":"3562413816387860"},"themes":[],"htmlText":"really??","listText":"really??","text":"really??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/382471502","repostId":"1108705396","repostType":4,"repost":{"id":"1108705396","kind":"news","pubTimestamp":1613469786,"share":"https://www.laohu8.com/m/news/1108705396?lang=&edition=full","pubTime":"2021-02-16 18:03","market":"us","language":"en","title":"With Biden going big, Wall Street economists are growing bullish on the US economy","url":"https://stock-news.laohu8.com/highlight/detail?id=1108705396","media":"CNN Business","summary":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a doubl","content":"<p><b>New York (CNN Business)&nbsp;</b>The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington&nbsp;and millions of families were about to&nbsp;lose crucial benefits.</p>\n<p>Fast forward two months, and the&nbsp;economy is still struggling-- but confidence in the recovery is growing, rapidly.</p>\n<p>Economists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.</p>\n<p>The renewed optimism is being driven by two major factors: the&nbsp;health crisis is easing&nbsp;and Uncle Sam is&nbsp;coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.</p>\n<p>After supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.</p>\n<p>\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.</p>\n<p>The turning point happened last month&nbsp;when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for&nbsp;President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.</p>\n<p><b>'Summer mini-boom'</b></p>\n<p>Before the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a&nbsp;forecast by Treasury Secretary Janet Yellen.</p>\n<p>\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.</p>\n<p>Oxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.</p>\n<p>Likewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"</p>\n<p>\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.</p>\n<p>Indeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.</p>\n<p>The rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.</p>\n<p><b>Double-dip recession averted</b></p>\n<p>The Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.</p>\n<p>For months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.</p>\n<p>At the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.</p>\n<p>\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.</p>\n<p>Slammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States&nbsp;added just 49,000 jobs in January.</p>\n<p>Jobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.</p>\n<p><b>Vaccines to the rescue</b></p>\n<p>But there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.</p>\n<p>Critically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.</p>\n<p>And Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday&nbsp;that the United States may be able to vaccinate most Americans by the middle or end of summer.</p>\n<p>All of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.</p>\n<p>That's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants&nbsp;force US states and cities to once again tighten health restrictions.</p>\n<p><b>Low-wage workers are still hurting badly</b></p>\n<p>Against this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.</p>\n<p>\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"</p>\n<p>Doing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.</p>\n<p>Employment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.</p>\n<p>\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.</p>\n<p>However, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.</p>\n<p>\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.</p>\n<p><b>'Bring it on'</b></p>\n<p>Some economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington&nbsp;overheats the economy by injecting too much support.</p>\n<p>\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.</p>\n<p>And that in turn would spook the&nbsp;red-hot stock market.</p>\n<p>Fed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.</p>\n<p>Citing \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.</p>\n<p>Zandi isn't losing sleep over inflation, mostly because the United States is far from full employment.</p>\n<p>\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Biden going big, Wall Street economists are growing bullish on the US economy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Biden going big, Wall Street economists are growing bullish on the US economy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-16 18:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and ...</p>\n\n<a href=\"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108705396","content_text":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and millions of families were about to lose crucial benefits.\nFast forward two months, and the economy is still struggling-- but confidence in the recovery is growing, rapidly.\nEconomists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.\nThe renewed optimism is being driven by two major factors: the health crisis is easing and Uncle Sam is coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.\nAfter supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.\n\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.\nThe turning point happened last month when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.\n'Summer mini-boom'\nBefore the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a forecast by Treasury Secretary Janet Yellen.\n\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.\nOxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.\nLikewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"\n\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.\nIndeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.\nThe rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.\nDouble-dip recession averted\nThe Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.\nFor months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.\nAt the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.\n\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.\nSlammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States added just 49,000 jobs in January.\nJobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.\nVaccines to the rescue\nBut there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.\nCritically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.\nAnd Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday that the United States may be able to vaccinate most Americans by the middle or end of summer.\nAll of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.\nThat's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants force US states and cities to once again tighten health restrictions.\nLow-wage workers are still hurting badly\nAgainst this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.\n\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"\nDoing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.\nEmployment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.\n\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.\nHowever, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.\n\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.\n'Bring it on'\nSome economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington overheats the economy by injecting too much support.\n\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.\nAnd that in turn would spook the red-hot stock market.\nFed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.\nCiting \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.\nZandi isn't losing sleep over inflation, mostly because the United States is far from full employment.\n\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":315846593,"gmtCreate":1612235641712,"gmtModify":1703759124387,"author":{"id":"3562413816387860","authorId":"3562413816387860","name":"firstfruits","avatar":"https://static.tigerbbs.com/10628f9c1ecd1b1ed688fe5c74ad3511","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562413816387860","authorIdStr":"3562413816387860"},"themes":[],"htmlText":"nice!!!","listText":"nice!!!","text":"nice!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/315846593","repostId":"1155510692","repostType":4,"isVote":1,"tweetType":1,"viewCount":1332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":315843557,"gmtCreate":1612235272179,"gmtModify":1703759120255,"author":{"id":"3562413816387860","authorId":"3562413816387860","name":"firstfruits","avatar":"https://static.tigerbbs.com/10628f9c1ecd1b1ed688fe5c74ad3511","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3562413816387860","authorIdStr":"3562413816387860"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/315843557","repostId":"1155510692","repostType":4,"isVote":1,"tweetType":1,"viewCount":1151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":false}